Test Price
2,800 AED✅ Home Collection Available
SNCA Gene (PARK1) Genetic Test for Parkinson’s Disease – DNA Labs UAE
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity – ISO 15189 & ISO 9001:2015 accredited NGS processing ensures clinical-grade accuracy.
- Premium Logistics – DHA-compliant, cold-chain home collection via certified phlebotomists (8 AM – 11 PM).
- Clinical Guidance – Telephonic post-test counselling with a DHA-licensed Consultant Medical Genetics included.
- Insurance Support – Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SNCA Gene (PARK1) Parkinson’s Disease Genetic Test analyzes the alpha-synuclein gene using next-generation sequencing to detect pathogenic variants linked to autosomal dominant Parkinson’s disease. This UAE-approved test supports early risk assessment, differential diagnosis, and informed family planning under strict genetic counselling protocols.
| Feature | Our Test (NGS) ISO-Certified UAE Lab |
Closest Alternative Conventional Sanger / Panel |
|---|---|---|
| Technology | Next-Generation Sequencing (NGS) | Standard Sanger Sequencing |
| Variant Resolution | Single-nucleotide, indel, CNV coverage | Targeted exons only (misses large rearrangements) |
| Reporting Standard | ACMG guidelines with clinical annotation | Binary mutation report without ACMG interpretation |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
“A positive SNCA variant does not mean an absolute Parkinson’s diagnosis; clinical correlation with motor, autonomic and cognitive symptoms is essential. Genetic test results must be interpreted within the full neurological picture, and I strongly recommend post-test genetic counselling for all family members.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠️ Medication Safety Notice
Do not discontinue prescribed Parkinson’s medication or adjust dosage without consulting your treating physician. Abrupt withdrawal can lead to severe dyskinesia or neuroleptic malignant syndrome.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Individuals under 18 years without a UAE court order for genetic testing as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- Exclusion: Inability to provide informed consent or absence of a legal guardian.
- Exclusion: Recent blood transfusion (<2 weeks) or active infection interfering with DNA integrity.
- Seek emergency care if you experience: sudden worsening of tremor, severe hallucinations, chest pain, or signs of neuroleptic malignant syndrome (high fever, rigidity, confusion).
Patient FAQ & Clinical Guidance
1. What does the SNCA gene Parkinson’s test actually detect?
Answer: This test identifies pathogenic mutations in the SNCA gene that cause or increase the risk of hereditary Parkinson’s disease.
2. Who should consider this genetic test in the UAE?
Answer: Individuals with a strong family history of early-onset Parkinson’s or atypical tremor syndromes benefit most from this analysis.
3. How is the sample collected and how long until I receive my report?
Answer: A certified phlebotomist collects a small blood sample (or FTA card spot); results are finalized in 3 to 4 weeks.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – All genetic data processed with explicit consent and encrypted storage.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – Secure IT infrastructure for handling sensitive medical records.
- Federal Decree-Law No. 4 of 2016 on Medical Liability – Governs patient consent and genetic counseling prior to testing.
- ISO 9001:2015 Certified – Cert. INT/EGQ/2509DA/3139
- DHA Facility License: 1143
Clinical & Logistical Metadata
| Test Name | SNCA Gene (PARK1) Parkinson’s Disease Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Whole blood (EDTA), extracted DNA, or FTA card blood spot. VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM. |
| Methodology Used | Next-Generation Sequencing (NGS) – Whole gene sequencing with CNV detection |
| ICD-10-CM Code | Z13.83 (Encounter for screening for genetic disease) |
| LOINC Code | 94266-0 (SNCA gene mutation analysis in blood or tissue by sequencing) |
| DHA Facility License & Laboratory Address | DHA License: 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians